COMBINATION IRON DEPLETION THERAPY

被引：50

作者：

TAETLE, R

HONEYSETT, JM

BERGERON, R

机构：

[1] UNIV CALIF SAN DIEGO,CTR CANC,DIV HEMATOL ONCOL,SAN DIEGO,CA 92103

[2] UNIV CALIF SAN DIEGO,CTR CANC,DIV LAB MED,SAN DIEGO,CA 92103

[3] UNIV CALIF SAN DIEGO,CTR CANC,DEPT PATHOL,SAN DIEGO,CA 92103

[4] UNIV CALIF SAN DIEGO,CTR CANC,DEPT MED,SAN DIEGO,CA 92103

[5] UNIV CALIF SAN DIEGO,CTR CANC,CANC BIOL PROGRAM,SAN DIEGO,CA 92103

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1989年 / 81卷 / 16期

关键词：

D O I：

10.1093/jnci/81.16.1229

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1229 / 1235

页数：7

共 47 条

[11] EFFECTS OF DIFFERENT TRANSFERRIN FORMS ON TRANSFERRIN RECEPTOR EXPRESSION, IRON UPTAKE, AND CELLULAR PROLIFERATION OF HUMAN-LEUKEMIC HL60 CELLS - MECHANISMS RESPONSIBLE FOR THE SPECIFIC CYTOTOXICITY OF TRANSFERRIN-GALLIUM [J].

CHITAMBAR, CR ;

SELIGMAN, PA .

JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06) :1538-1546

[12]

CHITAMBAR CR, 1987, CANCER RES, V47, P3929

[13]

CHITAMBAR CR, 1988, BLOOD, V72, P1930

[14]

ERIKSSON S, 1984, J BIOL CHEM, V259, P1695

[15] INVITRO CYTO-TOXICITY OF DEFEROXAMINE ON HUMAN MARROW HEMATOPOIETIC PROGENITORS [J].

ESTROV, Z ;

COHEN, A ;

GELFAND, EW ;

FREEDMAN, MH .

TOXICOLOGY IN VITRO, 1988, 2 (02) :131-134

[16]

ESTROV Z, 1987, BLOOD, V69, P757

[17]

FORSBECK K, 1987, EUR J HAEMATOL, V39, P318

[18]

FOSTER BJ, 1986, CANCER TREAT REP, V70, P1311

[19] SERIAL STUDIES OF AUDITORY NEUROTOXICITY IN PATIENTS RECEIVING DEFEROXAMINE THERAPY [J].

GALLANT, T ;

BOYDEN, MH ;

GALLANT, LA ;

CARLEY, H ;

FREEDMAN, MH .

AMERICAN JOURNAL OF MEDICINE, 1987, 83 (06) :1085-1090

[20] TRANSFERRIN RECEPTORS IN HUMAN-TISSUES - THEIR DISTRIBUTION AND POSSIBLE CLINICAL RELEVANCE [J].

GATTER, KC ;

BROWN, G ;

TROWBRIDGE, IS ;

WOOLSTON, RE ;

MASON, DY .

JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (05) :539-545

← 1 2 3 4 5 →